Lifetime risk for patients with mitral valve prolapse of developing severe valve regurgitation requiring surgeryWILCKEN, D. E. L; HICKEY, A. J.Circulation (New York, N.Y.). 1988, Vol 78, Num 1, pp 10-14, issn 0009-7322Article

Age and the clinical profile of idiopathic mitral valve prolapseHICKEY, A. J; WILCKEN, D. E. L.British heart journal. 1986, Vol 55, Num 6, pp 582-586, issn 0007-0769Article

Homocystinuria and atherosclerosisWILCKEN, D. E. L; DUDMAN, N. P. B.Monographs in Human Genetics. 1992, Vol 14, pp 311-324, issn 0077-0876Article

Association between an angiotensinogen microsattelite marker in children and coronary events in their grandparentsBADENHOP, R. F; WANG, X. L; WILCKEN, D. E. L et al.Circulation (New York, N.Y.). 1996, Vol 93, Num 12, pp 2092-2096, issn 0009-7322Article

Circulating lipid hydroperoxide levels in human hyperhomocysteinemia : relevance to development of arteriosclerosisDUDMAN, N. P. B; WILCKEN, D. E. L; STOCKER, R et al.Arteriosclerosis and thrombosis. 1993, Vol 13, Num 4, pp 512-516, issn 1049-8834Article

Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease : The result of a meta-analysisBRATTSTRÖM, L; WILCKEN, D. E. L; ÖHRVIK, J et al.Circulation (New York, N.Y.). 1998, Vol 98, Num 23, pp 2520-2526, issn 0009-7322Article

Interactive effect of the p53 gene and cigarette smoking on coronary artery diseaseWANG, X. L; WANG, J; WILCKEN, D. E. L et al.Cardiovascular research. 1997, Vol 35, Num 2, pp 250-255, issn 0008-6363Article

Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiographyWANG, X. L; MCCREDIE, R. M; WILCKEN, D. E. L et al.Arteriosclerosis, thrombosis, and vascular biology. 1995, Vol 15, Num 8, pp 1030-1034, issn 1079-5642Article

A sluicing device for reproducibly measuring the strength of attachment of cultured cells to their substrateDUDMAN, N. P. B; HICKS, C; WILCKEN, D. E. L et al.Analytical biochemistry. 1987, Vol 164, Num 1, pp 35-38, issn 0003-2697Article

Circulating transforming growth factor β1 and coronary artery diseaseWANG, X. L; LIU, S.-X; WILCKEN, D. E. L et al.Cardiovascular research. 1997, Vol 34, Num 2, pp 404-410, issn 0008-6363Article

Body mass index in Australian children: recent changes and relevance of ethnicityLYNCH, J; XING LI WANG; WILCKEN, D. E. L et al.Archives of disease in childhood. 2000, Vol 82, Num 1, pp 16-20, issn 0003-9888Article

Genetic polymorphism of heparan sulfate proteoglycan (Perlecan, HSPG2), lipid profiles and coronary artery disease in the Australian populationHUA CAI; XING LI WANG; WILCKEN, D. E. L et al.Atherosclerosis. 2000, Vol 148, Num 1, pp 125-129, issn 0021-9150Article

Common DNA polymorphisms at the lipoprotein lipase gene : Association with severity of coronary artery disease and diabetesWANG, X. L; MCCREDIE, R. M; WILCKEN, D. E. L et al.Circulation (New York, N.Y.). 1996, Vol 93, Num 7, pp 1339-1345, issn 0009-7322Article

Decreases in Apolipoprotein(a) after renal transplantation : implications for lipoprotein(a) metabolismBLACK, I. W; WILCKEN, D. E. L.Clinical chemistry (Baltimore, Md.). 1992, Vol 38, Num 3, pp 353-357, issn 0009-9147Conference Paper

The effect of weight reduction on left ventricular mass: a randomized controlled trial in young, overweight hypertensive patientsMACMAHON, S. W; WILCKEN, D. E. L; MACDONALD, G. J et al.The New England journal of medicine. 1986, Vol 314, Num 6, pp 334-339, issn 0028-4793Article

Independence of mitral valve prolapse and neurosisHICKEY, A. J; ANDREWS, G; WILCKEN, D. E. L et al.British heart journal. 1983, Vol 50, Num 4, pp 333-336, issn 0007-0769Article

Apolipoprotein screening in Australian children : feasibility and the effect of age, sex, and ethnicityLYNCH, J. F; MARSHALL, M. D; WANG, X. L et al.Medical journal of Australia. 1998, Vol 168, Num 2, pp 61-64, issn 0025-729XArticle

Plasma extracellular superoxide dismutase levels in an Australian population with coronary artery diseaseWANG, X. L; ADACHI, T; SIM, A. S et al.Arteriosclerosis, thrombosis, and vascular biology. 1998, Vol 18, Num 12, pp 1915-1921, issn 1079-5642Article

¹H NMR determination of urinary betaine in patients with premature vascular disease and mild homocysteinemiaLUNDBERG, P; DUDMAN, N. P. B; KUCHEL, P. W et al.Clinical chemistry (Baltimore, Md.). 1995, Vol 41, Num 2, pp 275-283, issn 0009-9147Article

An indirect sandwich ELISA for LP(a) in serum and dried blood spotsWANG, X. L; WILCKEN, D. E. L; DUDMAN, N. P. B et al.Clinica chimica acta. 1992, Vol 207, Num 1-2, pp 73-86, issn 0009-8981Article

Changes of allele-specific expression of apo(a) gene in infants during first year of lifeWANG, X. L; WILCKEN, D. E. L; DUDMAN, N. P. B et al.Lancet (British edition). 1992, Vol 340, Num 8816, issn 0140-6736, p. 431Article

Human arterial endothelial cell detachment in vitro : its promotion by homocysteine and cysteineDUDMAN, N. P. B; HICKS, C; WANG, J et al.Atherosclerosis. 1991, Vol 91, Num 1-2, pp 77-83, issn 0021-9150Article

Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: possible implications for prevention of vascular diseaseWILCKEN, D. E. L; DUDMAN, N. P. B; TYRRELL, P. A et al.Metabolism, clinical and experimental. 1988, Vol 37, Num 7, pp 697-701, issn 0026-0495Article

Screening for familial hypercholesterolemia in 5000 neonates: a recall studyBLADES, B. L; DUDMAN, N. P. B; WILCKEN, D. E. L et al.Pediatric research. 1988, Vol 23, Num 5, pp 500-504, issn 0031-3998, 5 p.Article

Insulin-like growth factor-I decreases serum lipoprotein(a) during long-term treatment of patients with Laron syndromeLARON, Z; WANG, X. L; KLINGER, B et al.Metabolism, clinical and experimental. 1996, Vol 45, Num 10, pp 1263-1266, issn 0026-0495Article